Varsha Gandhi

Professor & Chair ad interim

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Varsha Gandhi is a Professor & Chair ad interim at The University of Texas MD Anderson Cancer Center, USA. Her research focuses on molecular subtypes of chronic lymphocytic leukemia, mechanisms of protein stability in B-cell malignancies, and potential therapeutic strategies for T-cell acute lymphoblastic leukemia. Her recent publications reflect her expertise in transcriptomic and proteomic studies, as well as combination therapies in leukemia treatment.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Varsha Gandhi

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Transcriptomic and proteomic differences in BTK-WT and BTK-mutated CLL and their changes during therapy with pirtobrutinib

Ibrutinib and venetoclax in combination for chronic lymphocytic leukemia: synergy in practice

Transcriptomic clustering of chronic lymphocytic leukemia: molecular subtypes based on Bruton’s tyrosine kinase expression levels

Mechanisms of MCL-1 Protein Stability Induced by MCL-1 Antagonists in B-Cell Malignancies

DHODH: a promising target in the treatment of T-cell acute lymphoblastic leukemia

Publisher’s Note: Lymphatics, a New Open Access Journal

Pirtobrutinib inhibits wild-type and mutant Bruton’s tyrosine kinase-mediated signaling in chronic lymphocytic leukemia

Correction to: Activation of ATM kinase by ROS generated during ionophore‑induced mitophagy in human T and B cell malignancies

Ibrutinib combinations in CLL therapy: scientific rationale and clinical results

Activation of ATM kinase by ROS generated during ionophore-induced mitophagy in human T and B cell malignancies

Collaborators (5)

Steven Kornblau

Nitin Jain

Aloke SARKAR

William Wierda

Yana Pikman

Make your next move.